Soft-tissue sarcoma

During active treatment, medical records documenting the diagnosis and the ongoing treatment — operative reports, radiation therapy records, chemotherapy administration records, or records of other therapeutic procedures — establish that the 100 percent rating applies. Records showing the date treatment ended are also important, because they set the clock on the required six-month continuation period.

After treatment ends and the mandatory VA examination occurs, the evidence that matters most depends on whether the sarcoma has recurred or spread. Pathology reports, imaging studies such as CT or MRI scans, and oncology notes showing the presence or absence of local recurrence or metastasis are directly relevant. If there is no recurrence or spread, records and statements showing how any remaining physical limitations affect your ability to move, work, or carry out daily activities help establish the level of residual functional impairment.